Skip to main content
Regent Pacific Group Limited logo

Regent Pacific Group Limited — Investor Relations & Filings

Ticker · 575 ISIN · KYG3042R1314 LEI · 549300TF362HOIC4TJ34 HKEX Financial and insurance activities
Open in API
Filings indexed 1,267 across all filing types
Latest filing 2021-01-11 Capital/Financing Update
Country KY Cayman Islands
Listing HKEX 575

About Regent Pacific Group Limited

http://www.regentpac.com

Regent Pacific Group Limited is an investment holding company primarily focused on the healthcare and life sciences sectors globally. The company specializes in growth and value-led investments, particularly targeting late-stage life sciences assets and biopharma companies. Its core strategy involves building a powerful portfolio of investments intended for commercialization, often achieved through out-licensing agreements with strategic pharmaceutical partners. Regent Pacific operates across key markets, including Europe, the United States, and the Asia Pacific region. A significant area of focus is the longevity medicine business, which utilizes advanced AI technology following the acquisition of Deep Longevity Inc., positioning the company as an engine for emerging AI-driven biopharma solutions.

Recent filings

Filing Released Lang Actions
Operations update on Fortacin
Capital/Financing Update Classification · 95% confidence The document is an announcement dated 11 January 2021 from Regent Pacific Group Limited, providing an operations update on Fortacin™, a pharmaceutical product. It discusses findings from a third-party marketing consultant regarding US payer willingness to cover the product, pricing expectations, and market access strategies. The document includes forward-looking statements and cautions for investors. There are no financial statements, quarterly or annual results, audit information, or regulatory certifications included. The content is focused on operational updates and strategic market information rather than financial performance or governance changes. The document is longer than 5,000 characters and is not merely announcing the release of a report but providing substantive operational information. This fits best under the category of a Capital/Financing Update (CAP) as it relates to commercial strategy, market access, and potential partnership negotiations, which are typical of financing and capital-related operational updates. It is not an earnings release or annual/interim report, nor a regulatory filing or management report. Therefore, the most appropriate classification is CAP with high confidence.
2021-01-11 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/12/2020, submitted to the Hong Kong Exchanges and Clearing Limited by Regent Pacific Group Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. It includes confirmations related to the issuance and listing of securities. The content is focused on share capital changes and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements and confirmations to the stock exchange, consistent with a regulatory compliance document rather than a financial report or announcement of a report. The document length is substantial (15,000 characters), and it contains detailed data rather than a brief announcement or certification letter. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement about share capital movements and confirmations to the exchange, not fitting other more specific categories like Share Issue/Capital Change (SHA) because it covers a broad range of securities movements and confirmations in a regulatory format.
2021-01-06 English
Operations update on Fortacin
Capital/Financing Update Classification · 95% confidence The document is an announcement dated 4 January 2021 from Regent Pacific Group Limited providing an operations update on their product Fortacin™ (Senstend™). It discusses recent payments received, clinical trial approval status, clinical study details, manufacturing scale-up, and progress towards US FDA approval and commercialization. The content is focused on operational and commercial progress rather than financial results or detailed financial statements. It is not a full financial report, earnings release, or regulatory filing. The document is longer than 5,000 characters and contains substantive operational information but does not contain financial statements or detailed financial analysis. It is an update on company operations and strategic progress, which fits best under Capital/Financing Update (CAP) as it relates to commercial and clinical development milestones and associated payments, which impact the company's capital and financing outlook. Therefore, the most appropriate classification is CAP with high confidence.
2021-01-04 English
Supplemental announcement relating to offer to grant share option
Director's Dealing Classification · 95% confidence The document is an announcement dated 30 December 2020 from Regent Pacific Group Limited regarding the acceptance of an offer to grant share options to a director of certain subsidiaries. It references a previous announcement about the share option scheme and confirms the acceptance and effect of the option grant. The content focuses on share option grants to directors, which is related to changes in share ownership or capital structure but specifically involves directors. This fits the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives. The document is short (2295 characters) and is not a full financial report or earnings release. It is not a general regulatory filing or a report publication announcement. Therefore, the best classification is DIRS with high confidence.
2020-12-30 English
Next Day Disclosure Return (Equity issuer - changes in issued share capital and/or share buybacks)
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' for a Main Board listed issuer, Regent Pacific Group Limited, and details changes in issued share capital and share buybacks. It includes specific data on share issues, repurchases, confirmations of compliance with listing rules, and related notes. The content focuses on disclosure of share capital changes and repurchase activities, consistent with regulatory requirements for reporting such events. It is not a full financial report, earnings release, or management discussion, but a regulatory disclosure about share capital changes and buybacks. This matches the description of 'Transaction in Own Shares' filings, which report company buybacks or sales of its own shares. The document length (8226 characters) and detailed data support it being the actual disclosure, not just an announcement. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2020-12-28 English
Offer to grant share option
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the offer to grant share options to a director of certain subsidiaries of the company. It details the terms of the share option grant, including the offer date, exercise price, exercise period, and conditions. The document references compliance with the HK Listing Rules and provides information about the share option scheme. There is no financial data, earnings information, or report attached or referenced as being published. The content is focused on a capital-related event, specifically the granting of share options, which is a form of capital change. Therefore, the document fits best under the category of Share Issue/Capital Change (SHA). The document length is 5320 characters, which is sufficient for a detailed announcement but not a full report. Hence, the classification is SHA with high confidence.
2020-12-18 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.